Evidence map›Paper›PMID 39348412›Full record

ArticlePLoS computational biology2024

Exploring the potential of structure-based deep learning approaches for T cell receptor design.

Helder V Ribeiro-Filho, Gabriel E Jara, João V S Guerra, Melyssa Cheung, Nathaniel R Felbinger, José G C Pereira, Brian G Pierce, Paulo S Lopes-de-Oliveira

Abstract read
In one paragraph

Article in PLoS computational biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Helder V Ribeiro-FilhoBrazilian Biosciences National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo, Brazil.ORCID 0000-0001-8471-207X
Gabriel E JaraBrazilian Biosciences National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo, Brazil.ORCID 0000-0002-5831-1392
João V S GuerraBrazilian Biosciences National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo, Brazil.ORCID 0000-0002-6800-4425
Melyssa CheungInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, United States of America.ORCID 0000-0002-3232-2034
Nathaniel R FelbingerInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, United States of America.
José G C PereiraBrazilian Biosciences National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo, Brazil.ORCID 0000-0003-1041-0209
Brian G PierceInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, United States of America.ORCID 0000-0003-4821-0368
Paulo S Lopes-de-OliveiraBrazilian Biosciences National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo, Brazil.ORCID 0000-0002-1287-8019

Funding

High resolution modeling and design of immune recognitionR35GM144083 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI Brian G. Pierce · 2022 to 2026
$1.6M
NIGMS NIH HHS R35 GM144083
6 · The paper itself

Abstract

Deep learning methods, trained on the increasing set of available protein 3D structures and sequences, have substantially impacted the protein modeling and design field. These advancements have facilitated the creation of novel proteins, or the optimization of existing ones designed for specific functions, such as binding a target protein. Despite the demonstrated potential of such approaches in designing general protein binders, their application in designing immunotherapeutics remains relatively underexplored. A relevant application is the design of T cell receptors (TCRs). Given the crucial role of T cells in mediating immune responses, redirecting these cells to tumor or infected target cells through the engineering of TCRs has shown promising results in treating diseases, especially cancer. However, the computational design of TCR interactions presents challenges for current physics-based methods, particularly due to the unique natural characteristics of these interfaces, such as low affinity and cross-reactivity. For this reason, in this study, we explored the potential of two structure-based deep learning protein design methods, ProteinMPNN and ESM-IF1, in designing fixed-backbone TCRs for binding target antigenic peptides presented by the MHC through different design scenarios. To evaluate TCR designs, we employed a comprehensive set of sequence- and structure-based metrics, highlighting the benefits of these methods in comparison to classical physics-based design methods and identifying deficiencies for improvement.

Indexed as

Computational BiologyDeep LearningReceptors, Antigen, T-CellHumansModels, MolecularProtein BindingProtein ConformationProtein EngineeringReceptors, Antigen, T-Cell

Identifiers

PMID39348412
PMCPMC11466415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.